Literature DB >> 11981277

Genetic susceptibility--molecular epidemiology of head and neck cancer.

Erich M Sturgis1, Qingyi Wei.   

Abstract

In parts of the developing world (South Central Asia in particular), squamous cell carcinoma of the head and neck (SCCHN) is one of the most common malignancies encountered. Although tobacco and alcohol are clearly defined as etiologic factors in these malignancies, clinical observations have suggested that inherited genetic factors put some individuals at increased risk for SCCHN. Emerging data (both phenotypic and genotypic) support this concept of genetic susceptibility to SCCHN and point to differences in DNA repair ability, carcinogen metabolism, and cell cycle control as the systems important to the risk of tobacco-induced malignancies. The ability to identify such high-risk individuals will have major influences on the practice of cancer prevention in the future.

Entities:  

Mesh:

Year:  2002        PMID: 11981277     DOI: 10.1097/00001622-200205000-00010

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  31 in total

1.  Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx.

Authors:  Lei Jin; Erich M Sturgis; Xiaolin Cao; Xicheng Song; Taufiq Salahuddin; Qingyi Wei; Guojun Li
Journal:  FASEB J       Date:  2013-02-21       Impact factor: 5.191

2.  Tyms double (2R) and triple repeat (3R) confers risk for human oral squamous cell carcinoma.

Authors:  Alexandre Medeiros Bezerra; Thalita Araújo Sant'Ana; Adriana Vieira Gomes; Aurora Karla de Lacerda Vidal; Maria Tereza Cartaxo Muniz
Journal:  Mol Biol Rep       Date:  2014-10-24       Impact factor: 2.316

3.  Gene-environment interactions of novel variants associated with head and neck cancer.

Authors:  Caihua Liang; Carmen J Marsit; E Andres Houseman; Rondi Butler; Heather H Nelson; Michael D McClean; Karl T Kelsey
Journal:  Head Neck       Date:  2011-11-02       Impact factor: 3.147

4.  Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck.

Authors:  Zhensheng Liu; Guojun Li; Sheng Wei; Jiangong Niu; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

5.  Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer.

Authors:  Semra Demokan; Deniz Demir; Yusufhan Suoglu; Erkan Kiyak; Ugur Akar; Nejat Dalay
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

6.  Recent Advances in Head and Neck Tumor Microenvironment-Based Therapy.

Authors:  Muzafar A Macha; Nissar A Wani; Rais A Ganai; Ajaz A Bhat; Abid Hamid; Sheema Hashem; Mohammad Haris; Sham S Chauhan; Mohammad A Zargar; Surinder K Batra
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  Association of NAT2 phenotype with risk of head and neck carcinoma: A meta-analysis.

Authors:  Youyang Zheng; Yong Li; Yaoshu Teng; Zhen Zhang; Xiaolin Cao
Journal:  Oncol Lett       Date:  2011-11-24       Impact factor: 2.967

8.  Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.

Authors:  Xicheng Song; Erich M Sturgis; Lei Jin; Zhongqiu Wang; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2013-02-25       Impact factor: 7.396

9.  Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck.

Authors:  Mark E Zafereo; Erich M Sturgis; Sal Aleem; Katrina Chaung; Qingyi Wei; Guojun Li
Journal:  Cancer Prev Res (Phila)       Date:  2009-04-28

10.  Polymorphisms in HIF-1alpha affect presence of lymph node metastasis and can influence tumor size in squamous-cell carcinoma of the glottic larynx.

Authors:  F Mera-Menéndez; A Hinojar-Gutiérrez; M Guijarro Rojas; J García de Gregorio; E Mera-Menéndez; J J Sánchez; M Quintanilla; L Cerezo; C Gamallo
Journal:  Clin Transl Oncol       Date:  2012-08-23       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.